{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 453317265
| ImageFile = JTE_7-31_molecular_structure.png
| ImageSize = 220px
| IUPACName = 2-[2-(4-hydroxyphenyl)ethyl]-5-methoxy-4-(pentylamino)-2,3-dihydro-1H-isoindol-1-one
| OtherNames = 
|Section1={{Chembox Identifiers
| Abbreviations = 
| CASNo_Ref = {{cascite|changed|??}}
| CASNo = 194358-72-0
| EINECS = 
| PubChem = 19363402
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 13767708
| SMILES = Oc1ccc(cc1)CCN3Cc2c(ccc(OC)c2NCCCCC)C3=O
| InChI = 1/C22H28N2O3/c1-3-4-5-13-23-21-19-15-24(14-12-16-6-8-17(25)9-7-16)22(26)18(19)10-11-20(21)27-2/h6-11,23,25H,3-5,12-15H2,1-2H3
| InChIKey = FMUMUYFMLZGXJR-UHFFFAOYAA
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H28N2O3/c1-3-4-5-13-23-21-19-15-24(14-12-16-6-8-17(25)9-7-16)22(26)18(19)10-11-20(21)27-2/h6-11,23,25H,3-5,12-15H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FMUMUYFMLZGXJR-UHFFFAOYSA-N
| RTECS =
| MeSHName = 
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = 
}}
|Section2={{Chembox Properties
| Formula = C<sub>22</sub>H<sub>28</sub>N<sub>2</sub>O<sub>3</sub>
| MolarMass = 368.469 g/mol
| Appearance =
| Density = 
| MeltingPt = 
| MeltingPt_notes =
| BoilingPt = 
| BoilingPt_notes = 
| Solubility = 
| SolubleOther = 
| Solvent = 
| pKa = 
| pKb = 
  }}
|Section7={{Chembox Hazards
| ExternalSDS = 
| EUClass = 
| MainHazards = 
| NFPA-H = 
| NFPA-F = 
| NFPA-R = 
| NFPA-S =
| RPhrases = 
| SPhrases = 
| RSPhrases =
| FlashPt = 
| AutoignitionPt = 
| ExploLimits = 
| PEL = 
  }}
}}

'''JTE 7-31''' is a selective [[cannabinoid receptor]] agonist invented by [[Japan Tobacco]].<ref name="WO 1997/029079">{{Ref patent2 |country= WO |number= 1997/029079 |status= granted |title= Novel compounds and pharmaceutical use thereof |pubdate= 1997-31-07 |gdate= 1997-14-08 |pridate= 1997-06-02 |inventor =Inaba T, Kaya T, Iwamura H }}</ref><ref name="US 6017919">{{Ref patent2 |country = US |number= 6017919 |status= granted |title= Compounds and pharmaceutical use thereof |pubdate= 1998-08-06 |gdate= 2000-01-25 |pridate= 1998-08-06 |inventor= Inaba T, Kaya T, Iwamura H }}</ref> It is a reasonably highly selective [[Cannabinoid receptor 2|CB<sub>2</sub>]] agonist, but still retains appreciable affinity at [[Cannabinoid receptor 1|CB<sub>1</sub>]], with a [[dissociation constant|K<sub>i</sub>]] of 0.088nM at CB<sub>2</sub> vs 11nM at CB<sub>1</sub>.

==Legality==
JTE 7-31 is illegal in [[Alabama]].<ref>[https://legiscan.com/AL/text/SB333/id/988417/Alabama-2014-SB333-Enrolled.pdf Alabama Senate Bill SB 333: Controlled Substances]</ref>

==See also==
* [[A-834,735]]
* [[JTE-907]]
* [[MDA-19]]
* [[N-(S)-Fenchyl-1-(2-morpholinoethyl)-7-methoxyindole-3-carboxamide]]
* [[S-444,823]]
* [[XLR-12]]

==References==
{{reflist}}

{{Cannabinoids}}
{{cannabinoid-stub}}

[[Category:Cannabinoids]]
[[Category:Japan Tobacco]]